Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nexgel (NXGL) Common Equity (2018 - 2025)

Historic Common Equity for Nexgel (NXGL) over the last 8 years, with Q3 2025 value amounting to $5.6 million.

  • Nexgel's Common Equity rose 1183.31% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year increase of 1183.31%. This contributed to the annual value of $6.1 million for FY2024, which is 1769.26% up from last year.
  • As of Q3 2025, Nexgel's Common Equity stood at $5.6 million, which was up 1183.31% from $5.1 million recorded in Q2 2025.
  • In the past 5 years, Nexgel's Common Equity ranged from a high of $12.1 million in Q4 2021 and a low of $269000.0 during Q2 2021
  • For the 5-year period, Nexgel's Common Equity averaged around $5.9 million, with its median value being $5.6 million (2025).
  • Examining YoY changes over the last 5 years, Nexgel's Common Equity showed a top increase of 1692112.68% in 2021 and a maximum decrease of 3900.23% in 2021.
  • Quarter analysis of 5 years shows Nexgel's Common Equity stood at $12.1 million in 2021, then crashed by 36.81% to $7.6 million in 2022, then plummeted by 32.36% to $5.2 million in 2023, then increased by 17.69% to $6.1 million in 2024, then dropped by 8.29% to $5.6 million in 2025.
  • Its Common Equity stands at $5.6 million for Q3 2025, versus $5.1 million for Q2 2025 and $5.6 million for Q1 2025.